The evolving burden of drug use-associated infective endocarditis in the United States Sept. 19, 2022 Overview Show transcript Overview Juan A. Crestanello, M.D., is a cardiovascular surgeon and department chair of Cardiovascular Surgery at Mayo Clinic in Rochester, Minnesota. Dr. Crestanello, who specializes in surgery for valvular heart disease, discusses the evolving burden of drug use-associated infective endocarditis in the United States. Share Doximity Facebook LinkedIn Twitter Print details Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleDrug use impacts the care required by patients with infective endocarditisArticleTAILOR-PCI narrowly misses primary goal but indicates intriguing trends VID-20544823 Medical Professionals The evolving burden of drug use-associated infective endocarditis in the United States